Wapnick Pamela bought MGX
December 1, 2025 · Form 4 insider transaction
Wapnick Pamela bought 120,000 shares of Metagenomi Therapeutics, Inc. at $1.60 per share, a transaction worth $192.0K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
120,000
Price
$1.60
Total value
$192.0K
InsiderWapnick Pamela
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateDecember 1, 2025
Filing dateDecember 1, 2025
Shares owned after190,532
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
These shares represent RSUs. 50% of the RSUs shall vest on December 5, 2026, with the remainder vesting on December 5, 2027, subject to the Reporting Person's continued service with the Issuer on each such vesting date.